Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study


Heissigerova J., Callanan D., de Smet M. D. , Srivastava S. K. , Karkanova M., Garcia-Garcia O., ...Daha Fazla

OPHTHALMOLOGY, cilt.126, ss.428-437, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 126 Konu: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.ophtha.2018.09.044
  • Dergi Adı: OPHTHALMOLOGY
  • Sayfa Sayıları: ss.428-437

Özet

Purpose: To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).